동아에스티

170900KOSPI

54.7 / 100

Reference Date: 2026-09-08

Financial Score20.0 / 40

News Sentiment18.7 / 25

Momentum6.0 / 20

Disclosure10.0 / 15

AI Analysis: PBR is significantly undervalued vs. peers but ROE is below the industry average. Slightly down 4.0% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Dong-A ST, established in 2013 through a spin-off from Dong-A Pharmaceutical, focuses on manufacturing and selling specialty pharmaceuticals, medical devices, and pharmaceutical cosmetics. Key products include Grotrixin, Motiriton, and Suganon, with 2024 sales reaching 697.9 billion won, a 5.1% increase from the previous year. Growth was driven by the biopharmaceutical product Grotrixin and increased overseas exports.

Number of Employees

1,685people

Average Salary

78.9M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.004.0Point

PBR

0.53Industry Average 1.207.0Point

Half of industry avg (excellent)

ROE

-5.45Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

49.87Industry Average 100.006.5Point

Half of industry avg (excellent)

Trend 2023~20252.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲10.5% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼110.6% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -2.8% (declining, 3yr)

Detailed News Sentiment

19 totalPositive 14Neutral 4Negative 1Average Sentiment Score 74.7

Positive
동아에스티, 웨어러블 환자모니터링 기기 ‘하이카디’ 아시아 공급
동아시아 지역에서 동아에스티의 웨어러블 의료기기 '하이카디' 공급 계약 체결로 인해 회사의 성장 잠재력이 높아짐.
Positive
[바이오스냅] 동아ST, 동남아에 환자 모니터링 시스템 공급
동아시아 지역에 환자 모니터링 시스템 공급으로 동아에스티의 기술 리더십 강화 및 수출 확대 기대.
Neutral
하반기 신약 주인공 누구?…한미·셀비온·지엘-아주 '3파전'
The news discusses potential competition among multiple pharmaceutical companies for upcoming Korean drug approvals but does not directly impact 동아에스티's stock.

Detailed Momentum

52-week position3.0Point

52w lower range (20%)

Current 36,700Won52-week high 55,12552-week low 32,000

1-month return2.0Point

1m -4.05% (slight drop)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0

Neutral[기재정정]반기보고서 (2026.06)2026-08-20
Neutral반기보고서 (2026.06)2026-08-14